Eline Pottie

14PUBLICATIONS
47CO-AUTHORS
Biologically active moleculesCheminformatics and quantitative structure-activity relationshipsCharacterisation of biological macromoleculesBiomolecular modelling and designToxicology (incl. clinical toxicology)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (14)

|Jun 01, 2026
<i>N</i>‑Benzyl-Tryptamine Derivatives as Serotonin 5‑HT<sub>2</sub> Receptor Ligands: Synthesis and Structure-Affinity/Activity Relationships.

|Mar 20, 2026
<i>N</i>-Benzyl-tryptamine Derivatives as Serotonin 5-HT<sub>2A</sub> Receptor (5-HT<sub>2A</sub>R) Agonists: Focus on Different In Vitro 5-HT<sub>2A</sub>R Activity Profiles.

Eline Pottie, Emma Vertriest, Darío Martínez-Afani

|Nov 14, 2025
The psychedelic phenethylamine 25C-NBF, a selective 5-HT2A agonist, shows psychoplastogenic properties and rapid antidepressant effects in male rodents.

Núria Nadal-Gratacós, Pol Puigseslloses, Laura Guzmán

|Nov 05, 2025
The 4-alkyl chain length of 2,5-dimethoxyamphetamines differentially affects in vitro serotonin receptor actions versus in vivo psychedelic-like effects.

Dino Luethi, Grant C Glatfelter, Eline Pottie

|Oct 21, 2025
Neuropharmacology of halogenated DMT analogs: psychoplastogenic and antidepressant properties of 5-Br-DMT, a psychedelic derivative with low hallucinogenic potential.

Pol Puigseslloses, Núria Nadal-Gratacós, Berta Fumàs

|Aug 26, 2025
Pain management beyond opioids: a β-arrestin2-biased allosteric GPCR modulator opens new avenues for drug development.

Eline Pottie, Sophie A M Steinmüller, Michael Decker

Pageof 3

Frequent Collaborators

13 joint publications

Christophe Stove

3 joint publications

Annelies Cannaert

3 joint publications

Michael Decker

2 joint publications

David Pubill